Ticker Details
Bioventus Inc.
IPO Date:	February 11, 2021
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$827.88M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.25 | 3.41%
Avg Daily Range (30 D):	$0.37 | 3.85%
Avg Daily Range (90 D):	$0.28 | 2.91%

Institutional Daily Volume
Avg Daily Volume:	.34M
Avg Daily Volume (30 D):	.62M
Avg Daily Volume (90 D):	.48M

Trade Size
Avg Trade Size (Sh.):	88
Avg Trade Size (Sh.) (30 D):	62
Avg Trade Size (Sh.) (90 D):	56

Institutional Trades
Total Institutional Trades:	273
Avg Institutional Trade:	$1.26M
Avg Institutional Trade (30 D):	$1.05M
Avg Institutional Trade (90 D):	$.9M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.34M
Avg Closing Trade (30 D):	$1.06M
Avg Closing Trade (90 D):	$.88M
Avg Closing Volume:	149.61K

News

Jun 2, 2026 @ 11:00 AM Bioventus to Present at the Goldman Sachs 47TH Ann... Source: Na

May 22, 2026 @ 2:31 PM Regenerative Medicine's Newest Public Company Is B... Source: Usa News Group

Mar 12, 2026 @ 7:45 AM Orthobiologics Market to Surpass USD 9 Billion by ... Source: Mordor Intelligence

Aug 4, 2025 @ 12:00 PM Bioventus Enters into a New $400 Million Senior Se... Source: Dave Crawford

Apr 10, 2025 @ 5:30 AM Intramedullary Nail Market size to worth USD 1,537... Source: Coherent Market Insights

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$.43	$.05	$.22
Diluted EPS	$.41	$.04	$.21
Revenue	$576.3M	$132.09M	$157.9M
Gross Profit	$395.87M	$90.77M	$108.78M
Net Income / Loss	$34.54M	$3.95M	$17.32M
Operating Income / Loss	$57.52M	$8.42M	$19.49M
Cost of Revenue	$180.43M	$41.32M	$49.12M
Net Cash Flow	$13.04M	$-15.39M	$9.07M
PE Ratio